Biotech Values

[masterlongevity]

i agree with you on all points and made a mistake in my earlier post.
I think the community will see a 4 pt change as a break from SOC.

regarding disease modification, it is up in the air as a "standard definition", but i think a slowing of the natural progression + some biomarker data that shows changes in underlying pathology is what people are trying to achieve as a minimum